Is PTC Stock a Buy, Sell or Hold?
PTC (NASDAQ:PTC) is a maker of product lifecycle management software…
Sell
18
INFU Quote, Financials, Valuation and Earnings
Last price:
$6.09
Seasonality move
:
1.95%
Day range:
$6.03 - $6.23
52-week range:
$5.74 - $9.97
Dividend yield:
0%
P/E ratio:
61.10x
P/S ratio:
0.98x
P/B ratio:
2.26x
Volume:
193.5K
Avg. volume:
123.1K
1-year change:
-33.66%
Market cap:
$130M
Revenue:
$134.9M
EPS (TTM):
$0.10
Analysts' Opinion
-
Consensus RatingInfuSystems Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $14.13, InfuSystems Holdings has an estimated upside of 131.18% from its current price of $6.11.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $12.50 representing 100% downside risk from its current price of $6.11.
Fair Value
-
According to the consensus of 4 analysts, InfuSystems Holdings has 131.18% upside to fair value with a price target of $14.13 per share.
INFU vs. S&P 500
-
Over the past 5 trading days, InfuSystems Holdings has underperformed the S&P 500 by -20.99% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
InfuSystems Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
InfuSystems Holdings has grown year-over-year revenues for 14 quarters straight. In the most recent quarter InfuSystems Holdings reported revenues of $33.8M.
Earnings Growth
-
InfuSystems Holdings has grown year-over-year earnings for 3 quarters straight. In the most recent quarter InfuSystems Holdings reported earnings per share of $0.04.
Enterprise value:
153.3M
EV / Invested capital:
1.88x
Price / LTM sales:
0.98x
EV / EBIT:
22.43x
EV / Revenue:
1.14x
PEG ratio (5yr expected):
0.31x
EV / Free cash flow:
58.38x
Price / Operating cash flow:
50.21x
Enterprise value / EBITDA:
7.93x
Gross Profit (TTM):
$70.4M
Return On Assets:
2.23%
Net Income Margin (TTM):
1.74%
Return On Equity:
4.33%
Return On Invested Capital:
2.82%
Operating Margin:
7.73%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $109.9M | $125.8M | $134.9M | $31.8M | $33.8M | |
| Gross Profit | $60.6M | $63.1M | $70.4M | $16.7M | $18.2M | |
| Operating Income | $1.7M | $4.1M | $6.9M | $1.3M | $2.6M | |
| EBITDA | $14.9M | $16.5M | $19.3M | $4.4M | $6M | |
| Diluted EPS | -- | $0.03 | $0.10 | $0.00 | $0.04 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29.8M | $22.1M | $24.8M | $30.6M | $32.2M | |
| Total Assets | $97M | $97.6M | $99.4M | $102.9M | $103.6M | |
| Current Liabilities | $23M | $12.9M | $14.5M | $15.7M | $17.7M | |
| Total Liabilities | $56.2M | $49.3M | $51.4M | $50.6M | $46.1M | |
| Total Equity | $40.8M | $48.3M | $48M | $52.3M | $57.5M | |
| Total Debt | $38.8M | $33.1M | $33.2M | $29.1M | $23.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $17.5M | $11.2M | $20.5M | $4.7M | $7.9M | |
| Cash From Investing | -$11.5M | -$6.7M | -$13.2M | -$1M | -$3.3M | |
| Cash From Financing | -$6.1M | -$4.4M | -$6.9M | -$3.5M | -$4.5M | |
| Free Cash Flow | $2.4M | $106K | $2.6M | $2.7M | $2.8M | |
INFU
Sector
Market Cap
$130M
$38.8M
Price % of 52-Week High
61.28%
46.15%
Dividend Yield
0%
0%
Shareholder Yield
2.09%
-0.74%
1-Year Price Total Return
-33.66%
-38.89%
Beta (5-Year)
1.755
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$7.00
200-day SMA
Sell
Level
$7.28
Bollinger Bands (100)
Sell
Level
7.05 - 8.87
Chaikin Money Flow
Sell
Level
-2.7M
20-day SMA
Sell
Level
$7.67
Relative Strength Index (RSI14)
Sell
Level
27.33
ADX Line
Sell
Level
23.5
Williams %R
Buy
Level
-97.193
50-day SMA
Sell
Level
$7.94
MACD (12, 26)
Sell
Level
-0.46
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
540.6K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.2512)
Buy
CA Score
(Annual)
Level (0.4925)
Buy
Beneish M-Score
(Annual)
Level (-3.2839)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (0.0184)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.
Stock Forecast FAQ
In the current month, INFU has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The INFU average analyst price target in the past 3 months is $14.13.
-
Where Will InfuSystems Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that InfuSystems Holdings share price will rise to $14.13 per share over the next 12 months.
-
What Do Analysts Say About InfuSystems Holdings?
Analysts are divided on their view about InfuSystems Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that InfuSystems Holdings is a Sell and believe this share price will drop from its current level to $12.50.
-
What Is InfuSystems Holdings's Price Target?
The price target for InfuSystems Holdings over the next 1-year time period is forecast to be $14.13 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is INFU A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for InfuSystems Holdings is a Buy. 4 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of INFU?
You can purchase shares of InfuSystems Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase InfuSystems Holdings shares.
-
What Is The InfuSystems Holdings Share Price Today?
InfuSystems Holdings was last trading at $6.09 per share. This represents the most recent stock quote for InfuSystems Holdings. Yesterday, InfuSystems Holdings closed at $6.11 per share.
-
How To Buy InfuSystems Holdings Stock Online?
In order to purchase InfuSystems Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Stocks Have Largest Share Buybacks Now?
In February 2025 alone, over 160 companies announced new buyback…
Is Disney Stock a Bargain After Recent Challenges?
All is not well with entertainment behemoth The Walt Disney…
Stock Ideas
Buy
62
Is AAPL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 39x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
86
WLDN alert for Mar 8
Willdan Group [WLDN] is up 29.67% over the past day.
Buy
76
PDEX alert for Mar 8
Pro-Dex [PDEX] is up 19.69% over the past day.
Sell
7
IOT alert for Mar 8
Samsara [IOT] is down 15.54% over the past day.
